BPI-7711 Capsule in Patients With EGFR Mutation T790M Positive Non-small Cell Lung Cancer
Clinical trial NCT03386955 · COMPLETED
Trial details
- NCT number
- NCT03386955
- Sponsor
- Beta Pharma Shanghai
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-16
- Primary completion
- 2021-12-23
- Enrollment
- 215
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.